Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Nursing & Healthcare International Journal Research Article 10 min read

Nursery Science and Conventions

Lu DY*, Chen YZ and Lu DF
* Corresponding author
ISSN: 2575-9981  10.23880/nhij-16000203  Received: September 07, 2019  Published: September 27, 2019
 — views
 58 references
 3 tables
PDF
Keywords
Healthcare Nursing Medical service Modern technology Education Personalized medicine Obesity Psycho-analysis
Abstract

A great proportion of medical science needs high-quality nursery and technical assistance. Nursery science is pervasive across all medical disciplines. Nonetheless, the distribution and education of nursery science is under-performed worldwide. The quality and diversity of nursing services and technical support can be improved from medical science advances, propaganda, economic optimizing, clinical validation and updates. Patient’s nursery service plays key roles in modern hospitals. To promote these kinds of medical and technical work, new nursery systems must be implemented for quality promotion and disease treatments. Patient’s nursery service plays key roles in modern hospitals. To promote these kinds of medical and technical work, new nursery systems must be implemented for quality promotion and disease treatments. This article addresses medical promotion of a number of nursery sciences and effective projects—including college education, talent recruits, personal training, medical knowledge advances, distribution, convention evolution, clinical requirements, technical innovation and most important (financial supports and status improvements).

Introduction

Historic Overview

Today, medical science developments continue to progress. Their treatment processes are not defined in operation-room (surgery) and drug utility (chemical, herbal or bioagents) [1]. Getting better in the bedside and nursery demand new generation of medical services (surgery, drug, nutrition and instruments) and nursery service (physical or spiritual assistance) [1, 2, 3, 4]. Healthcare improvements remain to greatly improve with and without huge financial supports [5, 6, 7, 8, 9, 10, 11, 12, 13]. A great deal of chronic or dying patient in a general hospital can be better served by program of both doctors and nursing [14, 15, 16, 17]. Rapid progress of nursery service receives health-care reward and patient recognition.

Current Progress

Medical care and nursing advances help patient’s recovery and disease controls in the clinic. The medical significance of the quality improvements of medical healthcare and nursing activity is notable [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]. Nursery science and activity continue to progress in a rapid manner [10, 11, 12]. Many medical knowledge advances will certainly translate into new form in the bedside. Following methodology is useful means to teach all nurses.

Methods

General Methodology in Different Medical Discipline

There is no nursery knowledge that can be applied on every medical discipline. However, it suggests that knowledge spread should target different biomedical disciplines as much as possible [16]. (Table 1) and Table 2 show a glimpse of major skills that nurses in every discipline should be familiar with and get acquaintance onto [13, 14, 15, 16, 17, 18] (Tables 1 & 2).

Disease typesMajor targets
InfectionBody temperature, isolation, vaccination and drug uses
ObstetricChild, mother, human fertility, fetus observation
Mental disordersExcitement, agitation, cognitive, depression, excite
OncologySurgery, drugs and emergency
Metabolic diseaseObesity, nutrients, drug and life-style
OrthopedicsImmobile and osteoporosis
CardiovascularBlood pressure, electrocardiography and angiography
HandicapsLimb/foot, blind, deaf and speechless
PediatricHelping-hands for the children
Gastro-intestinalBleed and digests

Table 1: A general picture of nursery services for major diseases.

Major disciplinesTechnical catalogRequirements
Surgery and anesthesiaLocal or whole-bodyIndividual conditions
PsychiatricCognitive, behavior and emotionalSuicidal risk and custody
EmergencyBlood, respiratory and life indicatesTesting and support
PharmacologyEfficacy and toxicity monitorsCareful observation
NurseryDifferent medical disciplinesPhysical and spiritual
Patient conditionGender and agesEmphasize for categories

Table 2: Medical service from technical and health-care requirements.

It is not difficult to see the capability promotion of nurses can improve patient’s health care. System developments for nursery should not be neglected in most hospitals. Hospitals provide nursery services according to their capability and interests. Excellent health care services and nurses should be targeted to most patients and proper nurses. As a result, individualized nursing systems should be established in the upcoming decades and more hospitals. Major parts of nursery education

  • Nursery recruitment (different backgrounds and gender).
  • Early training (every details of hospital convention).
  • Basic skill familiar (patient feeding and supports).
  • Pharmacology (therapeutic outcome observation).
  • Drug side-effects (check-out therapeutic toxicity and mistake).
  • Assistance for doctor.
  • Diagnosis assistance (blood or urine tests).
  • Nutrition knowledge (maintaining the health of patients).
  • Communication skills.
  • Patient’s psychiatric-index and condition (cognitive, behavior and emotions).

Pharmacological Knowledge

Currently, different personalized medicines are gearing up in more global hospitals [18, 19, 20, 21, 22, 23, 24]. Entering into this millennium, technical, drug developments, clinical pharmacology, toxicology and education for nurses increase dramatically. Since the patho-physiological conditions are different from patient to patient. The different patho-physiological conditions, like body mass index (BMI), patient age, size and height, comorbidity, and other complications need different healthcare services and medical disciplines [25, 26, 27, 28]. Doctors are often not able to guide all these different services, especially drug toxicology and monitor. Cost balance between doctors’ diagnosis/prescription and patients’ nursing activity to individual patients will be future avenues. Otherwise, nurses will also report some treatment mistakes from doctors to higher regulatory levels and network— including drug toxicology and therapeutic failures [29].

Patient Emotion Control

Patients are often anxiety, agitated, excited or depressed by the agony of disease progress or relieving while treatment outcomes are different from their expectation. Patient’s psychiatric condition is often not stable. Careful spiritual supports can change the course of disease recovery [11]. We must keep in mind for this kind of medical services and make it a therapeutic routine.

Diversity of Nursery Work

A great different functionality in the hospitals is performed by nurses (Table 3). In order to do so, nurses are required to do a lot of different activity and services. They need to have this mindset before they are entered into hospitals and healthcare center.

CategoriesFunction
Doctor assistanceSurgery, drug distribution,
communication with family
Patient assistanceDrug administration, function
recovery
Basic diagnosisBlood glucose level or other test,
urine test, temperature
Basic administrationHospital function, data record,
room cleaming

Table 3: Categories of nursery service.

Future Directions

Joint Efforts

Therapeutics in the future is no longer a decision- making by doctors only [30, 31]. Many technical or assistance forces (including patients themselves) will take part of medical practice—including pharmacologists, pathologists, biochemical technologists, nurses, mathematicians and patient’s family members. Without the assistance of these experts and family members, clinical doctors will be narrow-minded and difficult to execute best therapeutics for all patients. This modern trend is unavoidable and eventually improving globally.

Targets for Different Disease Categories and Pharmacology

In summary, different types of nursery play key roles in different clinical trials and circumstances, especially chronic diseases, such as viral infection [32, 33, 34, 35], mental diseases [36, 37, 38, 39], bone disorders [40, 41, 42, 43], metabolic diseases [44, 45, 46, 47, 48, 49], cancer metastasis treatments [50, 51, 52, 53, 54, 55, 56, 57] and multi-targeted drugs [58]. After all, nursery should be familiar with all these knowledge of medical disciplines and execute their service in good details.

Conclusion

Patient’s nursery service plays key roles in modern hospitals. To promote these kinds of medical and technical work, new nursery systems must be implemented for quality promotion and disease treatments. After all, nursery activities should be more emphasized for all medical disciplines and patient treatments. No matter what kind of efforts we shall do, they are very useful in patient treatment and recovery after all.

References

  1. Lu DY, Lu TR (2019) Herbal medicine in new era. Hospice Palliative Medicine International J 3(4): 125- 130.
  2. Lu DY, Chen YZ, Lu DF, Che JY (2019) Patient’s care and nursery in different diseases. Hospice & Palliative Medicine International Journal 3(1): 28-30.
  3. Lu DY, Chen YZ, Lu DF, Che JY (2019) Patient’s care and nursery in modern medicine. Nursery Practice Health Care 1(1): 101.
  4. Lu DY, Chen YZ, Lu DF (2019) Nursery education, capability and service promotion. Open Access Journal of Nursing 2(2): 1-4.
  5. Iqbal U, Humayyn A, Li YC (2019) Healthcare quality improvement and measurement strategies and its challenges ahead. Int J Quality in Health Care 31(1): 1.
  6. Iqbal U, Rabrenovic M, Li YC (2019) Healthcare quality challenges in low- and middle-income countries. Int J Qual Health Care 31(3): 165.
  7. Lu DY, Che JY, Putta S, Wu HY, Shen Y (2019) How to improve the quality of pharmacotherapy for bone diseases. EC Orthopeadicis., 10 (6): 366-369.
  8. Leebov W, Scott G (1996) Service quality improvement. The customer satisfaction strategy for healthcare. J Healthcare Quality 18(4): 35.
  9. Lu DY, Chen YZ, Lu DF (2019) Nursery service, quality promotion. Hospice & Palliative Medicine International J 3(3): 97-98.
  10. Lu DY, Chen YZ, Lu DF, Che JY (2019) Nursery service in modern day. Adv Biomedical Engineering Biotechnology 1(3): 1-2.
  11. Lu DY (2019) Bone disease recovery strategies, nursery importance. EC Dental Science 18(6): 326- 327.
  12. Ghaffari M (2019) Building a community of learners: Lessons learned. Nursery Practice and Health Care 1(1): 104.
  13. (2013) An Old Disease, A New Insights, (Ed), Shamm Ahmad, Springer Science, US.
  14. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes; a 21st century challenge. Lancet Diabetes Endocrinol 2(1): 56-64.
  15. Grimaccia F, Kanavos P (2014) Cost, outcome, treatment pathways and challenges for diabetes care in Italy. Globalization Health 10: 58.
  16. Lu DY (2017) Suicide Risks and Treatments, New Ideas and Future Perspectives. In: Lu DY (Ed), Nova Science Publishers, New York, US.
  17. Lu DY (2017) HIV/AIDS Treatments, Fight for a Cure. In: Lu DY (Eds.), Lambert Academic Publishing Germany.
  18. Lu DY (2014) Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics, Woodhead Publishing, Elsevier, UK.
  19. Lu DY, Chen XL, Ding J (2006) Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment. Medical Hypotheses 66(1): 45-51.
  20. Lu DY, Lu TR, Ding J, Xu B, Che JY, et al. (2015) Anticancer drug sensitivity testing, a historical review and future perspectives. Current Drug Therapy 10 (1): 44-55.
  21. Lu DY, Lu TR, Xu B, Ding J (2015) Pharmacogenetics of cancer therapy: breakthroughs from beyond? Future Sci OA 1(4): FSO80.
  22. Lu DY, Lu TR, Che JY, Yarla NS (2018) Individualized cancer therapy, what is the next generation? EC Cancer 2(6): 286-297.
  23. Lu DY, Xu B, Ding J, Lu TR, Yarla NS, et al. (2018) Cancer Bioinformatics in Cancer Therapy. Adv Proteomics Bioinformatics pp: 1-7.
  24. Lu DY, Lu TR, Che JY, Shen Y, Yarla NS, et al. (2018) Individualized cancer therapy, future approaches. Current Pharmacogenomics & Personalized Medicine. 16(2): 156-163.
  25. Lu DY, Che JY, Putta S (2018) Obese study, keep up the momentum. Int J Endocrinology Res 1(1): 1-3.
  26. Lu DY, Che JY, Yarla NS, Putta S, Lin LP, et al. (2019) Human obesity, pathological and therapeutic advances. EC Pharmacology & Toxicology 7 (4): 231- 238.
  27. Lu DY, Che JY, Shen Y (2018) Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics 9(11): 781-782.
  28. Lu DY, Che JY, Shen ZM, Tong LJ, Lin LP, et al. (2019) Osteoporosis treatments for old people. EC Orthopeadicis 10(5): 278-280.
  29. Dirik HF, Samur M, Intepeler SS, Hewison A (2018) Nurses’ identification and reporting of medication errors. J Clin Nursing 28(5-6): 931-938.
  30. Lu DY, Zhu PP, Lu TR, Che JY (2016) The suicidal risks and treatments, seek medications from multi- disciplinary. Cent Nerv Syst Agents Med Chem 16(3): 231-239.
  31. Lu DY, Zhu PP, Wu HY, Lu Y, Che JY (2017) New modes of suicide/mental disorder diagnostics and therapeutics. In: Lu DY (Eds.), Suicide Risks and Treatments, New Ideas and Future Perspectives. (Chapter 5), Nova Science Publishers, US, pp: 51-62.
  32. Lu DY, Wu HY, Yarla NS, Xu B, Ding J, et al. (2018) HAART in HIV/AIDS treatments, future trends. Infect Disord Drug Targets 18(1): 15-22.
  33. Lu DY, Wu HY, Ding J, Sastry N, Lu TR (2016) HIV vaccine for prevention and cure, a mission possible. Rev Recent Clini Trials 11(4): 290-296.
  34. Lu DY, Lu TR, Wu HY, Yarla NS, Ding J, et al. (2018) HIV/AIDS curable study, new forms of therapeutic trinity. Rec Pat Antiinfect Drug Discov 13(3): 217- 227.
  35. Lu DY, Wu Hy, Yarla NS, Lu TR, Xu B, et al. (2019) Ebola therapeutic study and future trends. Infect Disorder Drug Targets 19(1): 17-29.
  36. Serafini G, Salano P, Amore M (2015) Suicidal ideation: a comprehensive overview. Suicidal Ideation: Predictors, Prevalence and Prevention. In: Weaver B (Eds.), (Chapter 1) Nova Science Publishing, US, pp: 1-42.
  37. While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, et al. (2012) Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and- after observational study. Lancet 379: 1005-1012.
  38. Lu DY, Lu TR, Lu Y, Cao S (2017) Introduction for suicide study. Journal Metabolic Syndrome 6(2): 227.
  39. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, et al. (2018) Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem 18(3): 206-212.
  40. Melton J (1993) Hip fracture: a worldwide problem today and tomorrow. Bone 14: S1-8.
  41. Silva DMW (2018) Diagnosis of osteoporosis; bone mineral density, risk factors, or both. EC Orthopaedics 9(7): 500-502.
  42. Lu DY, Che JY, Shen Y (2018) Osteoporosis in old women, therapeutic selection. EC Orthopaedics 9(7): 386.
  43. Lu DY, Che JY, Shen Y (2018) Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics 9(11): 781-782.
  44. Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, et al. (2017) Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications. Curr Pharm Des 23(30): 4475-4483.
  45. Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, et al. (2018) Type 2 diabetes study, introduction and perspective. The Open Diabetes J 8: 13-21.
  46. Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, et al. (2018) Type 2 diabetes treatment and drug development study. The Open Diabetes J 8: 22-33.
  47. Lu DY, Che JY, Lu Y, Yarla NS, Xu B, et al. (2018) An overview of obesity. Metabolomics 8(2): 200.
  48. Lu DY, Che JY, Wu HY, Yarla NS, Xu B, et al. (2018) Obesity, risks and managements. Metabolomics 8(1): e156.
  49. Lu DY, Che JY, Lu TR, Lu Y, Huang YK, et al. (2018) Pathology and treatments of obesity. Trends in Medicine 8(5): 1-2.
  50. Lu DY, Lu TR, Wu HY, Cao S (2013) Cancer Metastasis treatments. Current Drug Therapy 8(1): 24-29.
  51. Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) EMT 2016. Cell 166(1): 21-45.
  52. Lu DY, Lu TR, Xu B, Qi RX, Sastry NY, et al. (2016) Cancer metastasis, a clinical dilemma for therapeutics. Current Drug Therapy 11(2):163-169.
  53. Lu DY, Xu B, Ding J (2004) Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacology 4: 32.
  54. Lu DY, Huang M, Hu CX, Yang WY, Hu CX, et al. (2005) Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines. BMC Pharmacology 5:11.
  55. Lu DY, Chen XL, Ding J (2007) Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Medical Hypotheses 68(1): 188-193.
  56. Lu DY, Lu TR (2010) Antimetastatic activities and mechanisms of bisdioxopiperazine compounds. Anticancer Agents Med Chemi 10(7): 564-570.
  57. Lambert, AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168(4): 670-691.
  58. Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, et al. (2017) Anthocyanins: Possible role as multitarget therapeutic agents for prevention and therapy of chronic diseases. Current Pharmaceutical Design 23(41): 6321-6346.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{lu2019,
  title   = {Nursery Science and Conventions},
  author  = {Lu DY, Chen YZ and Lu DF},
  journal = {Nursing & Healthcare International Journal},
  year    = {2019},
  volume  = {3},
  number  = {5},
  doi     = {10.23880/nhij-16000203}
}
Lu DY, Chen YZ and Lu DF (2019). Nursery Science and Conventions. Nursing & Healthcare International Journal, 3(5). https://doi.org/10.23880/nhij-16000203
TY  - JOUR
TI  - Nursery Science and Conventions
AU  - Lu DY, Chen YZ and Lu DF
JO  - Nursing & Healthcare International Journal
PY  - 2019
VL  - 3
IS  - 5
DO  - 10.23880/nhij-16000203
ER  -